Stockscreener 앱 받기
3.63
3.20%
-0.12
시간 외 거래:
3.65
0.02
+0.55%
Kala Bio Inc 주식(KALA)의 최신 뉴스
Head-To-Head Survey: Equillium (NASDAQ:EQ) and KALA BIO (NASDAQ:KALA) - Defense World
Geode Capital Management LLC Has $426,000 Stake in Sidus Space, Inc. (NASDAQ:SIDU) - Defense World
Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World
Geode Capital Management LLC Boosts Holdings in KALA BIO, Inc. (NASDAQ:KALA) - Defense World
Wix.com Ltd [WIX] Insider Activity: An Update for Investors - knoxdaily.com
Understanding the Risks of Investing in CureVac N.V (CVAC) - knoxdaily.com
Recent Insider Activity Could Benefit Insperity Inc (NSP) - knoxdaily.com
Analyzing Kala Bio Inc (KALA) After Recent Trading Activity - knoxdaily.com
International Business Machines Corp [IBM] Stock sold by Insider Thomas Robert David for $6.72 million - knoxdaily.com
Aurora Cannabis Inc [ACB] Investment Guide: What You Need to Know - knoxdaily.com
Insider Sale Alert: Angi Inc [ANGI] – Is it Time to sell? - knoxdaily.com
Kala Bio Inc (KALA) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Kala Bio Inc (KALA) Stock: A Year of Market Fluctuations - investchronicle.com
Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com
Oppenheimer maintains Kala Bio stock Outperform with $15 target By Investing.com - Investing.com Canada
Kala Bio announces executive retention bonuses - Investing.com Australia
KALA stock touches 52-week low at $3.4 amid market challenges By Investing.com - Investing.com South Africa
Kala Bio announces executive retention bonuses By Investing.com - Investing.com South Africa
Kala Pharmaceuticals Announces Executive Retention Agreements - TipRanks
KALA stock touches 52-week low at $3.4 amid market challenges - Investing.com
Dynatrace, Inc. (NYSE:DT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Darling Ingredients Inc. (NYSE:DAR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Truist Financial Lowers Bank of New York Mellon (NYSE:BK) Price Target to $90.00 - Defense World
HC Wainwright Reaffirms “Buy” Rating for KALA BIO (NASDAQ:KALA) - Defense World
Kala Pharmaceuticals stock hits 52-week low at $4.05 - Investing.com India
Kala Pharmaceuticals stock hits 52-week low at $4.05 By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Kala Bio, target at $15 By Investing.com - Investing.com Canada
Kala Bio Inc Reports Q4 2024 Earnings: EPS Misses Estimate at -2 - GuruFocus
Simply Good Foods (SMPL) Expected to Announce Earnings on Wednesday - The AM Reporter
Oppenheimer maintains Outperform on Kala Pharmaceuticals stock - Investing.com Australia
Oppenheimer maintains Outperform on Kala Pharmaceuticals stock By Investing.com - Investing.com UK
KALA BIO: Q4 Earnings Snapshot - Huron Daily Tribune
KALA BIO Advances Eye Disease Therapies with New Funding - TipRanks
KALA BIO Inc. (KALA) reports earnings - Quartz
KALA BIO, Inc. SEC 10-K Report - TradingView
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - TradingView
North American Morning Briefing : Tariff Jitters -2- - Marketscreener.com
KALA BIO (KALA) Projected to Post Quarterly Earnings on Friday - Defense World
KALA BIO Inc expected to post a loss of $2.28 a shareEarnings Preview - TradingView
Comprehensive Insights of the Global Acute Ocular Pain Market: Key Drivers, Trends, Growth Opportunities, a... - WhaTech
KALA BIO (KALA) Expected to Announce Quarterly Earnings on Thursday - Defense World
PG’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Kala Bio appoints new interim CEO amid leadership shuffle - MSN
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference - TradingView
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million - The Manila Times
0.39%
3.66%
자본화:
|
볼륨(24시간):